CHICAGO, Sept. 9, 2019 /PRNewswire/ -- The AI in Advancement Advisory Council (AAAC), the first board actively shaping the future of the advancement industry

AUSTIN, Texas, Sept. 9, 2019 /PRNewswire/ -- BRC Recovery Family of Programs (BRC) announced today that Ruth Ann Rigby, CRS, former Director of Business Development at Capstone Treatment Center, is joining the organization as Chief Development Officer. Rigby will bring her extensive knowledge and experience to one of the country's premiere

7ACRES launches new proprietary premium strain, Jack Haze. Jack Haze is 7ACRES' first sativa-dominant strain with rare sensory characteristics. 7ACRES continues to achieve premium pricing with the launch of Jack Haze. TORONTO, Sept. 9, 2019 /PRNewswire/ -

RANCHO CORDOVA, Calif., Sept. 9, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary (the "Company"), filed a Form 8-K last Friday with the Securities and Exchange Commission announcing the signing of an excl

NEW YORK, Sept. 9, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that its confirmatory Phase 2 study of Bryostatin-1 in moderate to severe AD did not achieve statistical significance on the primary endpoint, whi

SAN DIEGO, Sept. 9, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) presented new patient-reported outcomes data for olorinab, an investigational, oral, periph

WARSAW, Ind., Sept. 9, 2019 /PRNewswire/ -- Johnson & Johnson Medical Devices Companies* announced today that DePuy Synthes** is launching the ATTUNE Cementless Knee in a rotating platform option in select markets around the world. This launch combines the proprietary technologies of the ATTUNE Knee designed to provide stability while the knee is in motion with

STOCKHOLM, Sept. 9, 2019 /PRNewswire/ -- Lipidor AB (publ) today reports that the last patient has been enrolled in the ongoing phase III study using calcipotriol spray against mild to moderate psoriasis. Results from the study are expected to be presented in December 2019. Lipidor has developed a sprayable calcipotriol product, Calcipotriol/AKVANO 50 µ

DENVER, Sept. 9, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company"), announced today that it has entered into a binding term sheet to acquire four additional dispensaries in Colorado from a leading cannabis retailer.

VANCOUVER, Sept. 9, 2019 /PRNewswire/ - Nextleaf Solutions Ltd. ("Nextleaf Solutions", "OILS", or the "Company") (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) announced today that Nextleaf Labs Ltd. ("Nextleaf Labs" or "Labs"), has received its Standard Processing Licence from Health Canada. This represents an im